Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Pigmentation: early-phase trial registry

2 of 5 indexed Pigmentation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Pigmentation: 5 US clinical trials tracked, 2 recruiting.

Pigmentation is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Integrative Skin Science and Research, running 2 of these trials.

Enrollment posture brief

Registry condition pigmentation

OPEN 2 | RECR 40% | LATE 0 | EARLY 1 | RANK #3391 | SPON 2

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Pigmentation (this)40%
Open-enrollment share among volume-matched conditions near Pigmentation

Pigmentation lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pigmentation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pigmentation is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Pigmentation research.

    Integrative Skin Science and Research accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Pigmentation trials plan to enrol fewer than 100 people.

    Median target enrolment is 25 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.

  4. Pigmentation research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Pigmentation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

PiQo4 Laser System Device
1 trials
Broadband Light Device
1 trials
0.9% Normal Saline (NS) Drug
1 trials
KB304 Biological
1 trials
Food: non-nut snack Other
1 trials
Food: whole almonds Other
1 trials
Topical Product: 0.025% Tretinoin oil augmented with castor oil Other
1 trials
Topical Product: Almond oil augmented with 0.5% Vitamin E Other
1 trials

US sites by state

Facility locations filed on Pigmentation trials. A trial with sites in several states counts in each.

California 3 trials
Texas 1 trials
New Jersey 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pigmentation page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pigmentation condition card totals 5 registered trials; most-linked intervention PiQo4 Laser System; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.